BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3812103)

  • 1. Studies of fibrinopeptide A, fibrinopeptide B beta 15-42, HMW-kininogen and kinin in cases of caesarean section.
    Mutoh S; Teh A; Saitoh M; Abe T; Ohno Y
    Adv Exp Med Biol; 1986; 198 Pt B():35-9. PubMed ID: 3812103
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of fibrinopeptide A, fibrinopeptide B beta 15-42 HMW-kininogen and kinin during normal pregnancy labor and puerperium.
    Mutoh S; Teh A; Saito M; Maki M; Abe T; Ohno Y
    Adv Exp Med Biol; 1986; 198 Pt B():41-4. PubMed ID: 3812106
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of coagulation-fibrinolysis factors in normal pregnancy, labor and puerperium and in cesarean section delivery.
    Tei A; Mutoh S; Yaoi Y; Saito M
    Bull Tokyo Med Dent Univ; 1989 Jun; 36(2):19-26. PubMed ID: 2776281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of acid-base balance and Apgar score on fibrinopeptide A and fibrinopeptide B beta 15-42 in umbilical cord blood].
    Ogura H; Adachi H; Takeda T; Nakagomi H; Kanno S; Yokoyama M; Kinoshita T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):128-34. PubMed ID: 3102647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of plasma fibrinopeptide assays.
    Owen J
    Thromb Haemost; 1989 Sep; 62(2):807-10. PubMed ID: 2814929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 8. Hominoid evolution as judged by fibrinopeptide structures.
    Doolittle RF; Wooding GL; Lin Y; Riley M
    J Mol Evol; 1971; 1(1):74-83. PubMed ID: 5006251
    [No Abstract]   [Full Text] [Related]  

  • 9. Assay of bovine fibrinopeptides by high performance liquid chromatography.
    Martinelli RA; Scheraga HA
    Anal Biochem; 1979 Jul; 96(1):246-9. PubMed ID: 495988
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
    Gando S; Tedo I; Tsujinaga H; Kubota M
    Masui; 1988 May; 37(5):541-5. PubMed ID: 3411777
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
    Tomura S; Oono Y; Kuriyama R; Takeuchi J
    Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and primary structures of duck fibrinopeptides A and B.
    Yuan M; Zhu P; Zhang YS
    Sci Sin B; 1985 Jan; 28(1):31-5. PubMed ID: 3983613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
    Miura M; Tomino Y; Inoue W; Yagame M; Tamura S; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Oct; 11(4):273-7. PubMed ID: 3617111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of coagulative and fibrinolytic factors in peripheral and ovarian veins among ovarian cancer patients].
    Ino Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2417-26. PubMed ID: 3130448
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the various causal factors related to hypercoagulability in the field of obstetrics - with special reference to the onset of DIC as viewed from the changing of kinin-kallikrein system and fibrinopeptide A.
    Suzuki S; Murakoshi T; Sakamoto W
    Adv Exp Med Biol; 1983; 156 (Pt B)():1055-65. PubMed ID: 6552855
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (Agkistrodon contortrix contortrix).
    Dyr JE; Hessel B; Suttnar J; Kornalík F; Blombäck B
    Toxicon; 1989; 27(3):359-73. PubMed ID: 2728027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low solubility fibrinogen examined by two-dimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing.
    Weinstein MJ; Deykin D
    Thromb Res; 1978 Sep; 13(3):361-77. PubMed ID: 741433
    [No Abstract]   [Full Text] [Related]  

  • 19. Assay of human fibrinopeptides by high-performance liquid chromatography.
    Ebert RF; Bell WR
    Anal Biochem; 1985 Jul; 148(1):70-8. PubMed ID: 4037309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.